INDUSTRY SYMPOSIUM // ITALFARMACO - New Insights and Clinical Outcomes in Duchenne Muscular Dystrophy

24 April 2024

SYMPO

• SYMPO4 • 12:00 > 13:00 • INDUSTRY SYMPOSIUM // ITALFARMACO - New Insights and Clinical Outcomes in Duchenne Muscular Dystrophy • 352 A+B

• SYMP4L1 • The Role of HDAC Inhibition as a Therapeutical Target in DMD > A. Annemieke AARTSMA-RUS (Leiden, The Netherlands) • SYMP4L2 • Assessing Milestones & Disease Progression in DMD > E. Eugenio MERCURI (Rome, Italy)